7YSE image
Entry Detail
PDB ID:
7YSE
Keywords:
Title:
Crystal structure of E. coli heterotetrameric GlyRS in complex with tRNA
Biological Source:
Host Organism:
PDB Version:
Deposition Date:
2022-08-12
Release Date:
2023-02-01
Method Details:
Experimental Method:
Resolution:
2.91 Å
R-Value Free:
0.25
R-Value Work:
0.22
Space Group:
P 2 2 21
Macromolecular Entities
Polymer Type:polypeptide(L)
Description:Glycine--tRNA ligase alpha subunit
Chain IDs:A, B
Chain Length:303
Number of Molecules:2
Biological Source:Escherichia coli K-12
Polymer Type:polypeptide(L)
Description:Glycine--tRNA ligase beta subunit
Chain IDs:C, D
Chain Length:697
Number of Molecules:2
Biological Source:Escherichia coli K-12
Polymer Type:polyribonucleotide
Description:RNA (76-MER)
Chain IDs:E, F
Chain Length:76
Number of Molecules:2
Biological Source:Escherichia coli
Primary Citation
The binding mode of orphan glycyl-tRNA synthetase with tRNA supports the synthetase classification and reveals large domain movements.
Sci Adv 9 eadf1027 eadf1027 (2023)
PMID: 36753552 DOI: 10.1126/sciadv.adf1027

Abstact

As a class of essential enzymes in protein translation, aminoacyl-transfer RNA (tRNA) synthetases (aaRSs) are organized into two classes of 10 enzymes each, based on two conserved active site architectures. The (αβ)2 glycyl-tRNA synthetase (GlyRS) in many bacteria is an orphan aaRS whose sequence and unprecedented X-shaped structure are distinct from those of all other aaRSs, including many other bacterial and all eukaryotic GlyRSs. Here, we report a cocrystal structure to elucidate how the orphan GlyRS kingdom specifically recognizes its substrate tRNA. This structure is sharply different from those of other aaRS-tRNA complexes but conforms to the clash-free, cross-class aaRS-tRNA docking found with conventional structures and reinforces the class-reconstruction paradigm. In addition, noteworthy, the X shape of orphan GlyRS is condensed with the largest known spatial rearrangement needed by aaRSs to capture tRNAs, which suggests potential nonactive site targets for aaRS-directed antibiotics, instead of less differentiated hard-to-drug active site locations.

Legend

Protein

Chemical

Disease

Primary Citation of related structures